Clinical Trial Results: A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated safety and immune response across different doses of a cytomegalovirus vaccine in healthy adults and has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections

Drugs mentioned

• GlaxoSmithKline cytomegalovirus vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cytomegalovirus Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-07-17